CNX-012-570, a direct AMPK activator provides strong glycemic and lipid control along with significant reduction in body weight; studies from both diet-induced obese mice and db/db mice models

Conclusions:
CNX-012-570 has the potential to control hyperglycemia and hyperlipidemia. It also reduces body weight gain with an additional benefit of minimizing cardiovascular risks in diabetics.

Source: Cardiovascular Diabetology - January 25, 2014 Category: Cardiology Authors: Tharappel AnilChandrashekaran HarishMudigere LakshmiKrishnaReddy HarshaMallappa OnkaramurthyVenkatesh Sathish KumarNitya ShreeVenkatachalaiah GeethaGundalmandikal BalamuraliAralakuppe GopalaBobbili Madhusudhan ReddyMadabosse GovindMammen AnupYoganand Mool Source Type: research